These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1789609)

  • 21. [Ultrastructural aspects of cholesteatoma of the middle ear].
    Paludetti G; Almadori G; Ottaviani F; Rosignoli M; Rossodivita M; D'Alatri L
    Acta Otorhinolaryngol Ital; 1989; 9(2):169-80. PubMed ID: 2763842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteatoma of the middle ear: An ultrastructural study.
    Schaper J; van de Heyning J
    Acta Otorhinolaryngol Belg; 1980; 34(1):12-5. PubMed ID: 7468191
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pathogenesis of so-called cholesteatoma of the middle ear].
    Ferlito A
    Otorinolaringol Ital; 1973; 39(3):185-201. PubMed ID: 4536451
    [No Abstract]   [Full Text] [Related]  

  • 24. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DNA cytometric studies of cholesteatoma of the middle ear].
    Bollmann R; Knopp U; Tolsdorff P
    HNO; 1991 Aug; 39(8):313-4. PubMed ID: 1938497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of epidermal hyperproliferation in patients with cholesteatoma.
    Aberg B; Edström S; Johannesson A; Larkö O
    Am J Otol; 1991 Mar; 12(2):93-6. PubMed ID: 2053612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histologic study of cholesteatoma in surgically treated otorrhea].
    González Méndez MV; Ballesteros Navarro JM; Aaki A
    Acta Otorrinolaringol Esp; 1989; 40(4):283-4. PubMed ID: 2629936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of the glandular structure in pathologically changed middle ear mucosa].
    Galle E; Reinsch M; Rose KG
    Z Laryngol Rhinol Otol; 1969 May; 48(5):345-51. PubMed ID: 5772020
    [No Abstract]   [Full Text] [Related]  

  • 30. [The study of proliferative epithelial activity in cholesteatoma of the middle ear during cytomorphophotometry].
    Amador JM; Esquivias JJ; Ciges M
    Acta Otorrinolaringol Esp; 1994; 45(2):71-8. PubMed ID: 8086212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mastocytes in chronic inflammation of middle ear mucosa].
    Sanković S; Dergenc R; Bojić P
    Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of retraction pockets in cholesteatoma development: an ultrastructural study.
    Akyildiz N; Akbay C; Ozgïrgïn ON; Bayramoglu I; Sayin N
    Ear Nose Throat J; 1993 Mar; 72(3):210-2. PubMed ID: 8482265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of class II antigen expressing cells in cholesteatoma epithelium.
    Aberg B; Jontell M; Edström S
    Acta Otolaryngol; 1988; 106(3-4):186-91. PubMed ID: 3176964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biology of cholesteatoma.
    Michaels L
    Otolaryngol Clin North Am; 1989 Oct; 22(5):869-81. PubMed ID: 2694066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S; Zheng X; Carlsöö B
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preservation of cochlear function after labyrinthine destruction--a report of 8 cases (author's transl)].
    Ohhashi M; Terayama Y; Tanaka K; Yamaji S
    Nihon Jibiinkoka Gakkai Kaiho; 1980; 83(2):147-52. PubMed ID: 7391852
    [No Abstract]   [Full Text] [Related]  

  • 37. [Factors determining the choice of technic in surgical treatment of cholesteatoma].
    Antolí-Candela Cano F; Leguizamón Medina G
    Acta Otorrinolaringol Esp; 1989 Dec; 40 Suppl 2():203-10. PubMed ID: 2627510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
    Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
    Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of middle ear ventilation on cholesteatoma development in experimental animals.
    Meyerhoff WL; Wright CG; Gerken GM
    Acta Otolaryngol; 1990; 110(3-4):279-85. PubMed ID: 2239219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cholesteatoma, oto- and tympanosclerosis: their general mechanism of tissue destruction (author's transl)].
    Mann W; Jonas I; Riede UN; Beck C
    Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):426-30. PubMed ID: 7202091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.